Momentus Holdings Inc. shares climbed sharply in pre-market action, rising 17.6% after the company revealed a commercial agreement with the University of Colorado Boulder’s Laboratory for Atmospheric and Space Physics (LASP). Under the deal Momentus will integrate and operate two Occultation Wave Limb Sounder (OWLS) instruments on its Vigoride-9 Orbital Service Vehicle, with a targeted launch scheduled for 2027.
The OWLS payloads are intended to perform space weather observations from orbit, adding a scientific-research component to Momentus’ expanding hosted-payload line of business. The announcement is notable because Vigoride-9 had been identified as having available capacity; the LASP contract therefore occupies that space on the mission manifest and creates concrete near-term revenue potential tied to the flight.
Investors also reacted positively to a broader set of recent developments at the company. Momentus has reported a fully subscribed Vigoride-8 mission slated for 2027 and has materially improved its liquidity position, raising roughly $76 million through institutional placements. Management has characterized that infusion as providing a multi-year operational runway to pursue its pipeline.
Market context helped amplify the move. In the premarket session Nasdaq 100 futures were up 0.6% and S&P 500 futures rose about 0.1%, following a broad semiconductor selloff the day prior that had pressured technology names. Dow Jones futures were relatively flat. The commercial space sector has also been in the spotlight after a high-profile market debut by SpaceX, which has been associated with a positive halo effect for smaller companies building orbital infrastructure such as Momentus.
Taken together, the combination of a fresh contract that fills Vigoride-9 capacity, a strengthened balance sheet backed by roughly $76 million in recent capital raises, and a sector narrative buoyed by investor attention has pushed Momentus higher in pre-market trading even as parts of the technology complex face selling pressure.
What the transaction means
The LASP agreement positions Momentus to host scientific payloads aboard a mission already part of its Vigoride series. By integrating and operating OWLS instruments on Vigoride-9, the company expands the mix of hosted services it can provide and secures revenue associated with that specific mission slot. The targeted 2027 launch date gives a timetable for when that revenue could be realized, contingent on the mission proceeding as planned.
Balance-sheet and pipeline
Momentus’ recent capital-raising activity, which produced about $76 million in cash from institutional placements, is cited by the company as providing multi-year operational runway. That additional liquidity follows the firm’s successful subscription of Vigoride-8, which is also planned for 2027, and supports execution across its manifested missions and payload integration activities.
Market dynamics
The broader market’s early strength in futures contracts and the elevated interest in commercial space equities after the high-profile SpaceX market debut have combined to create a favorable trading backdrop for Momentus. At the same time, the company’s share price is moving in a day when technology-heavy indexes are experiencing differential pressures, reflecting uneven sector dynamics.
Disclosure